Profile
Steffen Thiel was the founder of Helion Biotech ApS, serving as Chief Scientific Officer from 2009 to 2012, founded in 2008.
Dr. Thiel is the founder of Azanta Danmark AS, founded in 2000.
Former job at the University of Aarhus as Professor.
Education includes a doctorate from the University of Oxford and a graduate degree from the University of Southern Denmark.
Steffen Thiel active positions
| Companies | Position | Start |
|---|---|---|
Helion Biotech ApS
Helion Biotech ApS Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Founder | 29/07/2009 |
Former positions of Steffen Thiel
| Companies | Position | End |
|---|---|---|
University of Aarhus
University of Aarhus Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Azanta Danmark A/S
Azanta Danmark A/S Pharmaceuticals: MajorHealth Technology Develops protein therapeutics within orphan oncology and infectious diseases | Founder | - |
Training of Steffen Thiel
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Aarhus
University of Aarhus Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Southern Denmark
University of Southern Denmark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Azanta Danmark A/S
Azanta Danmark A/S Pharmaceuticals: MajorHealth Technology Develops protein therapeutics within orphan oncology and infectious diseases | Health Technology |
Helion Biotech ApS
Helion Biotech ApS Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
- Stock Market
- Insiders
- Steffen Thiel
















